These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15934910)

  • 1. Discovery and validation of drug targets for tumour angiogenesis.
    Kremmidiotis G; Lavranos TC
    Expert Opin Ther Targets; 2005 Apr; 9(2):211-5. PubMed ID: 15934910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic options to target angiogenesis in human malignancies.
    Herbst RS
    Expert Opin Emerg Drugs; 2006 Nov; 11(4):635-50. PubMed ID: 17064223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system.
    Sengupta S; Eavarone D; Capila I; Zhao G; Watson N; Kiziltepe T; Sasisekharan R
    Nature; 2005 Jul; 436(7050):568-72. PubMed ID: 16049491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antineovascular therapy, a novel antiangiogenic approach.
    Shimizu K; Asai T; Oku N
    Expert Opin Ther Targets; 2005 Feb; 9(1):63-76. PubMed ID: 15757482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of vascular-targeting drugs in a computational model of tumor growth.
    Gevertz J
    Phys Rev E Stat Nonlin Soft Matter Phys; 2012 Apr; 85(4 Pt 1):041914. PubMed ID: 22680505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor angiogenesis: a potential target in cancer control by phytochemicals.
    Singh RP; Agarwal R
    Curr Cancer Drug Targets; 2003 Jun; 3(3):205-17. PubMed ID: 12769689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug inhibition of angiogenesis.
    Madhusudan S; Harris AL
    Curr Opin Pharmacol; 2002 Aug; 2(4):403-14. PubMed ID: 12127873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer: one step at a time.
    Mooney D
    Nature; 2005 Jul; 436(7050):468-9. PubMed ID: 16049458
    [No Abstract]   [Full Text] [Related]  

  • 9. Targeting integrins for the control of tumour angiogenesis.
    Akalu A; Cretu A; Brooks PC
    Expert Opin Investig Drugs; 2005 Dec; 14(12):1475-86. PubMed ID: 16307488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Novel angiogenesis inhibitors for molecular target therapy of cancer].
    Osada H; Kakeya H
    Nihon Rinsho; 2004 Jul; 62(7):1257-63. PubMed ID: 15283141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenesis in glioblastoma multiforme: navigating the maze.
    Linkous AG; Yazlovitskaya EM
    Anticancer Agents Med Chem; 2011 Oct; 11(8):712-8. PubMed ID: 21707499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenesis inhibitors. Drug selectivity and target specificity.
    Kesisis G; Broxterman H; Giaccone G
    Curr Pharm Des; 2007; 13(27):2795-809. PubMed ID: 17897024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the tumor vascular compartment to improve conventional cancer therapy.
    Feron O
    Trends Pharmacol Sci; 2004 Oct; 25(10):536-42. PubMed ID: 15380938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of angiogenesis in solid tumours: an overview.
    Makrilia N; Lappa T; Xyla V; Nikolaidis I; Syrigos K
    Eur J Intern Med; 2009 Nov; 20(7):663-71. PubMed ID: 19818284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of vasculature targeting strategies for the treatment of cancer and chronic inflammatory diseases.
    Schraa AJ; Everts M; Kok RJ; Asgeirsdóttir SA; Meijer DK; de Leij LF; Molema G
    Biotechnol Annu Rev; 2002; 8():133-65. PubMed ID: 12436918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Setting sights on the treatment of ocular angiogenesis using antisense oligonucleotides.
    Henry SP; Marcusson EG; Vincent TM; Dean NM
    Trends Pharmacol Sci; 2004 Oct; 25(10):523-7. PubMed ID: 15380936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondria as targets in angiogenesis inhibition.
    Park D; Dilda PJ
    Mol Aspects Med; 2010 Feb; 31(1):113-31. PubMed ID: 19995570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenic targets for potential disorders.
    Bhadada SV; Goyal BR; Patel MM
    Fundam Clin Pharmacol; 2011 Feb; 25(1):29-47. PubMed ID: 20199582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour angiogenesis, vascular biology and enhanced drug delivery.
    Dass CR
    J Drug Target; 2004 Jun; 12(5):245-55. PubMed ID: 15512775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour targeting by microtubule-depolymerizing vascular disrupting agents.
    Kanthou C; Tozer GM
    Expert Opin Ther Targets; 2007 Nov; 11(11):1443-57. PubMed ID: 18028009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.